Results 151 to 160 of about 32,475 (204)

Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation [PDF]

, 1992
CS Higano, WH Raskind, Jack W. Singer
openalex   +1 more source

Extracellular vesicles enhance the in vivo antitumor effects of millettia species-derived compounds in chronic myelogenous leukemia therapy. [PDF]

Front Chem
Xie Z, Cheng X, Mao J, Zhu Y, Li L, Mei Z.   +5 more
europepmc   +1 more source

Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines [PDF]

, 1992
Brian J. Druker, Keiko Okuda, Ursula A. Matulonis, Ravi Salgia, Thomas M. Roberts, JD Griffin   +5 more
openalex   +1 more source

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy [PDF]

, 1994
JQ Guo, JY Lian, YM Xian, MS Lee, AB Deisseroth, SA Stass, RE Champlin, Moshe Talpaz, Jiu‐Yao Wang, R B Arlinghaus   +9 more
openalex   +1 more source

Identification of Philadelphia-negative granulocyte-macrophage colony- forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients [PDF]

, 1994
Carmelo Carlo‐Stella, L Mangoni, Giovanna Piovani, D. Garau, Camillo Almici, Vittorio Rizzoli   +5 more
openalex   +1 more source

Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection. [PDF]

Biomicrofluidics
Pinnenti M, Sami MA, Hassan U.
europepmc   +1 more source

Mutations of the N-ras gene in juvenile chronic myelogenous leukemia [PDF]

, 1994
J Miyauchi, M Asada, M Sasaki, Y Tsunematsu, S Kojima, S Mizutani   +5 more
openalex   +1 more source

Differences in the frequency of normal and clonal precursors of colony- forming cells in chronic myelogenous leukemia and acute myelogenous leukemia [PDF]

, 1992
ID Bernstein, Jack W. Singer, FO Smith, RG Andrews, DA Flowers, J Petersens, L Steinmann, Vesna Najfeld, David G. Savage, Steven Fruchtman   +9 more
openalex   +1 more source

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. [PDF]

Sci Rep
Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S.   +4 more
europepmc   +1 more source

AN AUTOPSY CASE OF SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH CHRONIC MYELOGENOUS LEUKEMIA

, 1981
Makiko ANNO, Yasumitu NAKAIDE, Masao Tanaka, Yutaka Hirota, Kazuo Hara   +4 more
openalex   +2 more sources